International Journal of Drug Delivery Technology · Jun 8, 2026

Ultrasound in the Assessment of Malnutrition: Integration into Clinical Pharmacy Practice

By Zea MAC, León MC, PAREDES JLS et al.

Background: Disease-related malnutrition is a multidimensional clinical syndrome characterized by reduced intake, inflammation, altered body composition, impaired function, and increased vulnerability to adverse outcomes. The GLIM framework recognizes reduced muscle mass as a key phenotypic criterion for malnutrition diagnosis, but routine muscle assessment remains difficult in many clinical settings because conventional body composition methods are not always feasible at the bedside. Nutritional ultrasound has emerged as a portable, non-invasive, radiation-free method for assessing muscle thickness, cross-sectional area, and muscle quality, particularly through rectus femoris evaluation. Recent evidence supports its usefulness in morphofunctional assessment and sarcopenia detection among nutritionally vulnerable patients. Objective: This mixed-methods implementation study aimed to evaluate the clinical and organizational value of integrating bedside nutritional ultrasound into clinical pharmacy practice for the assessment and management of adult hospitalized patients with or at risk of malnutrition. Methods: A quasi-experimental pre–post design was proposed, including 180 adult hospitalized patients receiving clinical pharmacy follow-up: 90 in a usual-care phase and 90 in a pharmacist-integrated ultrasound phase. Trained pharmacists performed standardized rectus femoris ultrasound in selected patients at nutritional risk. Quantitative outcomes included ultrasound-derived muscle parameters, GLIMcompatible malnutrition status, handgrip strength, phase angle, pharmacist-led nutrition-related interventions, referral to nutrition support, and exploratory clinical outcomes. A qualitative component included semi-structured interviews with pharmacists and multidisciplinary clinicians to explore feasibility, acceptability, workflow integration, role boundaries, and training needs. Results: GLIM-compatible malnutrition was identified in 62.2% of the total sample. In the ultrasoundintegrated phase, ultrasound-detected low muscle mass was present in 57.8% of patients and was significantly more frequent among those with GLIM-compatible malnutrition. Rectus femoris thickness and cross-sectional area were positively correlated with handgrip strength and phase angle, and negatively correlated with age, inflammatory burden, and length of hospital stay. Pharmacist-integrated ultrasound increased documented nutrition-related pharmacist interventions from 34.4% to 61.1%, including nutrition support referral, medication review for adverse effects affecting intake, dose reassessment in patients with suspected low muscle mass, and parenteral or enteral nutrition optimization. Qualitative findings indicated that clinicians perceived ultrasound as useful when applied selectively, supported by competency-based training, and interpreted within an interprofessional framework. Conclusions: Nutritional ultrasound may enhance clinical pharmacy practice by improving detection of low muscle mass, strengthening nutrition-related recommendations, and supporting pharmacotherapy optimization in nutritionally vulnerable patients. Its greatest value lies not in isolated image acquisition, but in its integration with GLIM-compatible assessment, morphofunctional evaluation, medication review, and interprofessional decision-making. Future multicenter studies using real patient data are needed to validate pharmacist-integrated ultrasound pathways and determine their impact on patient-centered outcomes.

doi.org/10.25258/ijddt.16.48s.92Open accessBiomarkers

AgingResearch.News